Free Trial

ProAssurance Co. (NYSE:PRA) Sees Large Decline in Short Interest

ProAssurance logo with Finance background

ProAssurance Co. (NYSE:PRA - Get Free Report) was the target of a large drop in short interest during the month of November. As of November 15th, there was short interest totalling 680,600 shares, a drop of 28.0% from the October 31st total of 945,100 shares. Based on an average daily trading volume, of 260,200 shares, the days-to-cover ratio is currently 2.6 days. Approximately 1.4% of the company's shares are sold short.

Hedge Funds Weigh In On ProAssurance

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Point72 Hong Kong Ltd bought a new stake in ProAssurance in the second quarter worth approximately $28,000. nVerses Capital LLC bought a new stake in ProAssurance in the third quarter worth approximately $44,000. Innealta Capital LLC bought a new stake in ProAssurance in the second quarter worth approximately $69,000. Point72 Asia Singapore Pte. Ltd. increased its holdings in ProAssurance by 94.3% in the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 8,347 shares of the insurance provider's stock worth $126,000 after purchasing an additional 4,052 shares in the last quarter. Finally, FMR LLC increased its holdings in ProAssurance by 197.8% in the third quarter. FMR LLC now owns 12,063 shares of the insurance provider's stock worth $181,000 after purchasing an additional 8,012 shares in the last quarter. Institutional investors and hedge funds own 85.58% of the company's stock.

ProAssurance Trading Down 0.1 %

Shares of NYSE PRA traded down $0.01 during midday trading on Friday, reaching $16.72. The stock had a trading volume of 130,985 shares, compared to its average volume of 280,403. The company's 50 day moving average price is $15.52 and its 200 day moving average price is $13.85. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.28 and a current ratio of 0.28. ProAssurance has a twelve month low of $10.76 and a twelve month high of $17.79. The firm has a market cap of $855.33 million, a price-to-earnings ratio of 20.16 and a beta of 0.24.

Wall Street Analyst Weigh In

PRA has been the topic of a number of research reports. Piper Sandler lowered shares of ProAssurance from an "overweight" rating to a "neutral" rating and set a $18.00 target price on the stock. in a report on Monday, November 11th. StockNews.com cut shares of ProAssurance from a "buy" rating to a "hold" rating in a research note on Tuesday, November 19th. Finally, Truist Financial raised their target price on ProAssurance from $14.00 to $18.00 and gave the stock a "hold" rating in a research report on Tuesday, November 12th. Three analysts have rated the stock with a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $18.67.

Get Our Latest Research Report on PRA

ProAssurance Company Profile

(Get Free Report)

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ I was wrong. Dead wrong. (From Porter & Company) (Ad)

Should you invest $1,000 in ProAssurance right now?

Before you consider ProAssurance, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProAssurance wasn't on the list.

While ProAssurance currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines